An Overview of Prospect and Challenges in Achieving End Tb Strategy Of 2030 - 2035; North Central Zone Nigeria, As A Focus: A Review

The Mycobacterium tuberculosis (M. tuberculosis) complex is one of the oldest recognized human harmful infectious diseases, it is one of the single greatest infectious disease killers in the world, and has been declared a worldwide emergency. The review study is aimed at determining the effectiveness of the treatment, management, control and prevention of tuberculosis inachieving End TB strategy 2030-2035 in north central zone of Nigeria. In thisretrospective review study, scientific literatures in electronic database of Google scholar, Pub Meds, and Scopus using search themes as tuberculosis, prevalence, risk factor, transmission and treatment were retrieved and examined. The incidence and prevalence of TB is not well documented in Nigeria, due to the fact that majority of individuals with the disease are not captured as a result of many being latent carriers of TB. Inability to properly diagnose the condition due to poor and inadequate infrastructures, lack of resources to provide the latest diagnostic services, lack of well-trained staff in the knowledge of the diagnosis of TB, accurate and reliable methods of diagnosis such as Interferon-gamma release assay (IGRA) has been a challenge in the North Central Zone(NCZ) of Nigeria. Latent carrier of TB due to inability to diagnose them and offer treatment is a huge challenge that could impede the policy of End TB Strategy 2030-2035. The health facilities where TB cases are managed should put in place adequate resources and well trained man power that would be able to provide accurate diagnosis to ensure proper treatment; these will facilitate early and complete eradication of the disease in NCZ and Nigeria; thereby achieving End TB Strategy 2030-2035.